L&P’s Client Argentum Pharmaceuticals Settles with Cosmo Technologies Ltd. in Patent Dispute over Uceris® Drug

Argentum Pharmaceuticals LLC, a generic pharmaceutical company represented by Laurence & Phillips IP Law (L&P), reached a settlement agreement with Cosmo Technologies Ltd. related to U.S. Patent No. 9,320,716.  The settlement agreement in IPR2018-00080 followed the filing of a petition for an inter partes review of U.S. Patent No. 9,320,716, which relates to the treatment of inflammatory bowel disease.  L&P partner Kevin Laurence was lead counsel for Argentum Pharmaceuticals in the IPR.